Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
LiveRamp
RAMP
$2.29B
| $11.6M | 0.02% |
585,690
+292,045
| +99% | +$5.63M |
|
|
JNPR
852
CALL
DELISTED
Juniper Networks
JNPR
| $11.6M | 0.02% |
450,000
| – | – |
|
853
National Fuel Gas
NFG
$7.84B
| $11.6M | 0.02% |
+231,461
| New | +$12.5M |
|
|
BRFS
854
DELISTED
BRF SA
BRFS
| $11.6M | 0.02% |
649,598
+36,708
| +6% | +$721K |
|
|
FPRX
855
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $11.5M | 0.02% |
750,191
+276,622
| +58% | +$5.94M |
|
856
B&G Foods
BGS
$284M
| $11.5M | 0.02% |
315,830
+38,589
| +14% | +$1.22M |
|
857
BHP
BHP
$247B
| $11.4M | 0.02% |
405,341
+171,799
| +74% | +$5.58M |
|
858
Old Republic International
ORI
$10.1B
| $11.4M | 0.02% |
730,811
+705,863
| +2,829% | +$11.3M |
|
|
CSG
859
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $11.4M | 0.02% |
1,760,262
+1,490,544
| +553% | +$10.6M |
|
860
Criteo S.A.
CRTO
$837M
| $11.4M | 0.02% |
303,618
+139,885
| +85% | +$6.4M |
|
861
DexCom
DXCM
$34.4B
| $11.4M | 0.02% |
528,908
-1,465,580
| -73% | -$32.7M |
|
862
CVR Energy
CVI
$3.82B
| $11.3M | 0.02% |
276,315
+135,870
| +97% | +$5.39M |
|
863
Dycom Industries
DY
$11.4B
| $11.3M | 0.02% |
156,145
+77,251
| +98% | +$5.35M |
|
|
HI
864
DELISTED
Hillenbrand
HI
| $11.3M | 0.02% |
432,518
+43,709
| +11% | +$1.21M |
|
865
Black Hills Corp
BKH
$5.49B
| $11.2M | 0.02% |
272,016
+150,208
| +123% | +$6.17M |
|
866
Comscore
SCOR
$73.6M
| $11.2M | 0.02% |
+12,172
| New | +$13.2M |
|
867
Vishay Intertechnology
VSH
$4.67B
| $11.2M | 0.02% |
1,159,277
-70,616
| -6% | -$749K |
|
868
Omega Healthcare
OHI
$14.1B
| $11.2M | 0.02% |
318,348
+294,427
| +1,231% | +$10.3M |
|
|
WLB
869
DELISTED
Westmoreland Coal Company
WLB
| $11.2M | 0.02% |
791,492
+17,331
| +2% | +$255K |
|
|
VRE
870
DELISTED
Veris Residential
VRE
| $11.1M | 0.02% |
590,382
+548,062
| +1,295% | +$10.8M |
|
871
Orthofix Medical
OFIX
$399M
| $11.1M | 0.02% |
329,807
+78,475
| +31% | +$2.79M |
|
872
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
| $11.1M | 0.02% |
343,334
+198,349
| +137% | +$7.34M |
|
873
Upbound Group
UPBD
$1.12B
| $11.1M | 0.02% |
457,831
-92,263
| -17% | -$2.48M |
|
874
CALL
Patterson-UTI
PTEN
$4.52B
| $11.1M | 0.02% |
+843,700
| New | +$13.4M |
|
|
TIVO
875
DELISTED
TIVO INC
TIVO
| $11.1M | 0.02% |
1,279,160
-28,661
| -2% | -$272K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.